LIGAND PHARMACEUTICALS INCORPORATED
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $38.9M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $39.9M |
| SG&A Expense | $15.2M |
| Operating Income | $-10.0M |
| Operating Margin | -25.6% |
| Interest Expense | $270.0K |
| Pretax Income | $-9.9M |
| Income Tax Expense | $-1.5M |
| Net Income | $-1.9M |
| Net Margin | -5.0% |
| EPS (Basic) | $-0.10 |
| EPS (Diluted) | $-0.10 |
| Shares Outstanding (Basic) | 18.9M |
| Shares Outstanding (Diluted) | 18.9M |
| Dividends Per Share | — |